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Abstract 
Objective: Standard rodent sepsis models as cecal ligation and puncture models (CLP) or cecal ligation and incision 
models (CLI) are frequently not suited experiments, mainly because they lack surgical repair, and they are difficult to 
control for severity. The colon ascendens stent peritonitis model (CASP) overcomes some of these limitations.
Result: Here we present our modification of the rodent CASP model, where severity of sepsis can be controlled by 
timing of surgical repair and treatment, and by diameter of the stent. Further, basic hemodynamic monitoring (blood 
pressure and heart rate) and frequent blood sampling can be achieved, which might guide further treatment.
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Introduction
Sepsis is a life-threatening organ dysfunction due to a 
dysregulated host response to infection [1] and is associ-
ated with high mortality and unfavorable outcome [2, 3]. 
Neither sepsis burden nor mortality has changed in the 
past decade [3]. Given the higher risk of acquiring sepsis 
and of adverse outcome in the elderly [4], with the aging 
population in many countries sepsis will remain and even 
will rise as one of the most important health care threats.
Since sepsis is a complex syndrome defined as organ 
dysfunction associated with dysregulated host response 
to infection [1, 4], preclinical research has to rely on ani-
mal models to explore the complex interaction of infec-
tious agents and host factors. Commonly used research 
models are endotoxin/toxin administration, exogenously 
administered pathogenic bacteria, and host-barrier dis-
ruption models, where the animals’ protective endog-
enous host barrier is altered. For practical and financial 
reasons, rodent models dominate over other species. The 
far most frequent models within this category are mod-
els where the intestinum is disrupted, and the intestinal 
content spills into the normally sterile peritoneal cavity 
and thus induces a polymicrobial sepsis. Cecal ligation 
and puncture (CLP models) and cecal ligation and inci-
sion (CLI models) are regarded as gold standard models 
because they resemble initiation and progression with 
characteristics of human sepsis, but this view has been 
challenged [5]. CLP and CLI do not completely mimic 
the representative course of human perforated intestine 
and are difficult to control in terms of severity and pre-
dictability. The colon ascendens stent peritonitis (CASP) 
model, first described in mice [6] and later in rats [7], 
overcomes this limitation.
In this manuscript, we describe the adaptations made 
to improve the CASP model in terms of monitoring 
hemodynamics and facilitating frequent blood sampling 
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Main text
Materials and methods
These experiments were performed as a pilot of a pro-
ject aiming to explore the effects of a new endotoxin 
scavenger as a randomized placebo-controlled trial, the 
results of the main experiments are not published in this 
manuscript.
The experiment was reviewed and approved by the 
Animal Care and Experimentation Committee of the 
Canton of Bern, Switzerland (26169 BE6/15) and fol-
lowed the Swiss national guidelines for the performance 
of animal experiments. Male Wistar rats aged 8–9 weeks, 
weighing 380  g in average were obtained from Janvier 
Labs (Le Genest‐Saint‐Isle, France) and kept in individu-
ally ventilated cages (IVC) with controlled 12 h light/dark 
cycles at 22 ± 2  °C at the Central Animal Facility of the 
University of Bern. Food and water were provided ad libi-
tum. A total of 56 animals were included (4 groups: 20 
animals sham surgery ± scavenger/placebo, 36 animals 
CASP ± scavenger/placebo).
Anesthesia
Anesthesia was induced with 6% sevoflurane (Sevorane, 
AbbVie, Baar, Switzerland) in oxygen in an induction 
chamber, and 50  µg/kg fentanyl (Janssen-Cilag, Zug, 
Switzerland) was added intraperitoneally. The animals 
were intubated using a modified 2.0 mm Angiocath (BD, 
Allschwil; Switzerland) and mechanically ventilated with 
a small animal ventilator (KTR-4 Rodent Ventilator, Hugo 
Sachs, March, Germany). Anesthesia was maintained 
with sevoflurane 2.5–3.5%, and analgesia with additional 
50  µg/kg fentanyl administered subcutaneously 30  min 
later. The animal was placed on an operation table with 
an in-built feedback controlled heater system (TCAT-2, 
Harvard Apparatus, Hugo Sachs, March, Germany) aim-
ing for a constant body temperature of 37 °C.
Preparation
After incision of the right groin, we tunneled two polyu-
rethan catheters (PU 40, SAI Infusion Technologies, Lake 
Villa, IL, USA with a redon needle/wound drainage tro-
car from the neck to the groin.The catheters were then 
equipped with a 1.5 to 2 cm tip made of PE-50, and filled 
with heparinized sterile normal saline solution (5000 I.U. 
heparin in 1000  ml NaCl 0.9%) via a blunt needle and 
luer lock syringe on the cranial part. The femoral artery 
and vein were microsurgically exposed, cannulated and 
secured with a suture. Before skin closure, the catheters 
were additionally bend as a loop and secured twice with 
sutures. The animals were turned in prone position and 
the catheters secured with a subcutaneous loop and 
suture at the neck. We channeled the catheters trough a 
tethered harness (SAI Infusion Technologies, Lake Villa, 
IL, USA) and connected them via a two channel swivel 
with 2 purge systems (syringe drivers) to guarantee free 
movement of the animal and integrity of the catheters. 
After drawing a first arterial and venous blood sample, 
both purge lines were continuously flushed with 1.5 ml/h 
Glucose 5% in  H2O 2:1 and heparin (5000 I.U. hepa-
rin in 1000  ml GS), to the arterial line purge we added 
buprenorphine (Temgesic, Reckitt Benckiser Switzer-
land, Wallisellen) to achieve a concentration of 1 µg/ml. 
The animals were weaned from the ventilator, extubated 
and placed for recovery from surgery in a cage equipped 
with a swivel mount. Duration of surgery was 50–60 min.
Colon ascendens stent peritonitis
6 hours after finishing the preparation the animals were 
re-anesthetized with sevoflurane 6% in oxygen, supple-
mented with 20  μg/kg buprenorphine subcutaneously. 
Anesthesia was maintained with 2.5 to 3.5% sevoflurane 
in oxygen via facemask. A median laparotomy was per-
formed, and the coecum and the ascending colon identi-
fied and exposed. A small incision was made about 1 cm 
distal the iliocoecal valve at the anti-mesenterial side, and 
a 12 French PU catheter of 1.5  cm length was inserted. 
This stent was additionally fixed to the colon by a suture. 
Patency was tested by instillation of saline into the stent, 
with spontaneous emptying of feces afterwards, or gen-
tle squeezing the coecum until intestinal content was 
visible in the opening of the stent. The animals in the 
sham group received the same surgery, omitting colos-
tomy, with the stent only sutured at the outer side of the 
colon ascendens. The intestine was packed back into the 
abdominal cave and the abdominal wall was closed in 
two layers. Surgical time was below 20 min. The animal 
was placed back into its cage equipped with the swivel 
mount. Volume replacement was started, the buprenor-
phine dosing was resumed. The animals were provided 
with water and nourishment ad libitum.
Surgical repair and treatment
16  hours after peritonitis induction and randomization, 
animals were again re-anesthetized as described before. 
The abdominal sutures were re-opened, the stent identi-
fied, which could necessitate exploration with sterile cot-
ton swabs to remove fibrin and detritus. Cultures from 
the abundant purulent ascites and detritus were taken at 
this time point for the main experiment. Once the stent 
was identified, the additional suture was cut, the stent 
removed and the intestinal wall closed with simple inter-
rupted stitchings. The abdominal cavity was then rinsed 
with warm Ringer’s solution, and the abdominal wall 
closed with sutures. Surgical time was below 20 min.
Then the rats were placed in their cages with the swivel 
mount. All animals received an intravenous infusion 
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of meropenem (Meronem, Pfizer Switzerland, Zurich, 
75 mg per kg BW, diluted to 5 mg/ml, in 15 min) followed 
by a continuous infusion via the central venous line 
(225 mg/kg BW/24 h). Analgesia was provided continu-
ously with buprenorphine administered via the intraarte-
rial purge line.
Blood pressure was measured continuously with a 
standard transducer system linked to a BIOPAC MP100 
analog–digital-converter and was acquired and analyzed 
with the Biopac AcqKnowledge Data Acquisition Soft-
ware (BIOPAC, Goleta, CA 93117, USA). Heart rate was 
calculated with the blood pressure tracing.
Blood samples were drawn 16 and 40 h post peritoni-
tis induction. After the last blood sampling the animals 
were euthanized by intravenous infusion of pentobar-
bital (150  mg/kg BW, Esconarkon, Streuli Pharma AG, 
Uznach, Switzerland).
Results
All but 2 animals survived the initial surgery. In the 
CASP group, 4 animals (out of 36) died or were eutha-
nized according to the score sheet after sepsis induc-
tion, before randomization. No further premature death 
occurred after randomization and start of the treatment. 
Blood sampling was achieved before peritonitis induction 
and before start of meropenem (6 h) in all animals. Line 
patency decreased over time, after 24  h, blood samples 
could not be obtained in 9 animals, but did not decrease 
further.
In the 6 animals where microbiological samples from 
the abdominal cavity were drawn at repair, polymicro-
bial growth of gram negative and gram positive bacteria 
in great quantity could be documented as a proof of the 
infection with intestinal pathogenes.
Because of the relatively long tubing system and con-
nection via the swivel system, blood pressure tracings 
were damped, so. We relied on mean arterial pressure. 
Although clear signs of peritonitis were seen, and cul-
tures grew abundant bacteria, systemic hypotension did 
not occur (mixed effects model for repeated measures 
data, p = ns, Fig.  1). Heart rate was significantly higher 
in the septic animals (mixed effects model, p = 0.005 for 
group, p = 0.02 for time, group x time factor: p = 0.04, 
Fig. 2).
In conclusion, the addition of the arterial and venous 
catheters in the CASP model expands the research possi-
bilities of the model. With these catheters, fluid manage-
ment and anti-infective as well as analgesic treatment can 
be individualized, and blood sampling is facilitated. By 
analogy with known literature, where needle size, num-
ber of punctures and length of ligation modifies severity 
of sepsis [8], and in view of the experience with patients, 
where timing of repair is crucial, we believe that this 
model can be used in a large variety of clinically relevant 
experiments.
Limitation
Traditional models have disadvantages depending on 
the research questions. Lipopolysaccharide injection 
models do not produce sepsis, but endotoxin shock; 
injection of bacteria or a defined amount of bacteria or 
Fig. 1 Blood pressure. Time course of blood pressure und septic (red) 
and sham (blue) animals. Note that measurement of blood pressure 
began 16 h after sepsis induction /sham surgery, when treatment 
with surgery and meropenem started. There are no significant 
differences between the groups
Fig. 2 Heart rate. Time course of heart rate und septic (red) and sham 
(blue) animals. Note that measurement of heart rate began 16 h after 
sepsis induction /sham surgery, when treatment with surgery and 
meropenem started. The difference between the groups is significant 
(p = 0.005)
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fecal slurry lack the pathophysiology of gut discontinu-
ation. In surgical models of abdominal sepsis abscess 
formation frequently occurs. This does not reflect the 
current medical scenario, where surgical treatment 
with closure of the gut discontinuation and lavage is 
attempted. The CASP model overcomes this draw-
back with surgical repair of the damage. Continuous 
bacterial contamination renders this model moder-
ately controllable, but adaptation of the model can be 
accomplished by different sizes of the stent [9], and by 
different timing of surgical repair. Continuous blood 
pressure and heart rate monitoring can guide fluid 
management with frequent adjustments. Together with 
the venous catheter, both lines enable blood sampling 
without posing additional stress to the animal, and safe 
and reliable dosing of medication.
In this pilot experiment we found that combining the 
vessel cannulation and the CASP surgery in one sin-
gle operation leads to an unacceptable high mortality. 
After modification and introducing a recovery period 
between both procedures the mortality during surgery 
declined. It is quite probable that the staged surger-
ies in this model induce inflammatory responses on 
its own and interfere with the results and outcomes 
on each step, but we have not quantified this effect. 
Another problem was failure to sample blood because 
of blocked catheters. Although we added heparin to the 
purge fluids, in some animals the catheter was partially 
clotted or developed a valve-like phenomena. With two 
lines in place, we could use the second line in some 
instances, but in 12%, no blood sampling was possible. 
We recommend a tubing system with biocompatible 
heparin bonded surfaces, or adding an anticoagulant 
to the animal, which would in turn increase the risk of 
hemorrhage during septic shock.
Because of the long tubing and the connection with a 
swivel, the arterial blood pressure curve was damped. 
Since tissue perfusion depends on mean arterial blood 
pressure this is not a major drawback [10]. It could be 
criticized that this model did not produce relevant hypo-
tonia and shock, as it would be expected in severe sepsis. 
Because of positive cultures of abundant bacteria with 
different species in the peritoneum, and the marked dif-
ferences in heart rate between the septic and the sham 
animals, we are certain that sepsis and shock occurred, 
but treatment with intravenous fluids via purge lines and 
antibiotics prevented clinical deterioration and death.
A general problem in research is the use of younger 
animals, as we have done. Age is a well-known contribu-
tor to mortality in patients, and in animal models of sep-
sis [11]. Generalizability to the elderly human population 
may be challenging.
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